C. difficile Risk — ORE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Clindamycin
Explanation lettering: E = shown as A · C = shown as B · D = shown as C · B = shown as D · A = shown as E
Clindamycin (A) is the correct answer. UK NICE guidance and multiple meta-analyses consistently identify clindamycin as carrying the highest risk of C. difficile infection among antibiotics, with a relative risk approximately 2–3 times greater than comparator antibiotics. Amoxicillin (B) is lower-risk; any CDI association is related to volume of use rather than inherent toxicity. Metronidazole (C) is used therapeutically for CDI, not a primary causative agent in this context. Phenoxymethylpenicillin (D) is a narrow-spectrum penicillin with minimal CDI risk. Doxycycline (E) is a tetracycline; evidence explicitly shows tetracyclines are not associated with increased CDI risk. This discriminates candidates who understand evidence-based antibiotic stewardship and UK guidance on prescribing safety.
Reference: NICE Medicines and Prescribing Briefing: Clostridium difficile infection: risk with broad-spectrum antibiotics. https://www.nice.org.uk/advice/esmpb1/chapter/key-points-from-the-evidence (2015)